IDH1 and astrocytoma (excluding glioblastoma): Our approach to exclusively analyze astrocytomas stratified for IDH1 mutation status from a consecutive LGG database reflects the effort to minimize biological confounders for surgical outcome analysis and clearly distinguishes this series from others published in literature.